Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial
In a groundbreaking advancement in the treatment of pancreatic ductal adenocarcinoma (PDAC), a notoriously aggressive and deadly form of cancer, researchers have unveiled promising results...
















